Literature DB >> 10680078

Antineoplastic chemotherapy of the older cancer patient.

L Balducci1, M B Corcoran.   

Abstract

Cancer chemotherapy may be effective and safe in older patients if some proper provisions are made. Doses of chemotherapy should be adjusted to the patient's glomerular filtration rate, and his or her hemoglobin should be maintained for the duration of the therapy. For patients who are 70 years of age or older and who are receiving moderately toxic chemotherapy, growth factors should be used. The risk of mucositis increases with the age of the patient, so it is important to treat it aggressively at the first signs of the complication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680078     DOI: 10.1016/s0889-8588(05)70284-7

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  20 in total

Review 1.  [Oncologic pharmacotherapy of elderly patients].

Authors:  U Wedding; U Merkel; K Farker; K Höffken
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

2.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

3.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

4.  History of cancer and mortality in community-dwelling older adults.

Authors:  Elizabeth Kvale; O James Ekundayo; Yan Zhang; Shamima Akhter; Inmaculada Aban; Thomas E Love; Christine Ritchie; Ali Ahmed
Journal:  Cancer Epidemiol       Date:  2010-08-13       Impact factor: 2.984

Review 5.  Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

Authors:  J Andrew Skirvin; Stuart M Lichtman
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer.

Authors:  Young Saing Kim; Se Hoon Park; Sun Young Kyung; Sun Jin Sym; Sang Pyo Lee; Jeong Woong Park; Sung Hwan Jung; Jinny Park; Eun Kyung Cho; Jae Hoon Lee; Dong Bok Shin
Journal:  Med Oncol       Date:  2010-03-03       Impact factor: 3.064

7.  Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Authors:  Arti Hurria; Kelly Brogan; Katherine S Panageas; Ann Jakubowski; Marjorie Zauderer; Carol Pearce; Larry Norton; Jane Howard; Clifford Hudis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.

Authors:  Brent S Pedersen; Panagiotis A Konstantinopoulos; Monique A Spillman; Subhajyoti De
Journal:  Genes Chromosomes Cancer       Date:  2013-05-28       Impact factor: 5.006

Review 9.  Colorectal cancer in the elderly: is palliative chemotherapy of value?

Authors:  Friedemann Honecker; Claus-Henning Köhne; Carsten Bokemeyer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part II: Metastatic Disease.

Authors:  Addie Hill; Eutiquio Gutierrez; Jennifer Liu; Sarah Sammons; Gretchen Kimmick; Mina S Sedrak
Journal:  Drugs Aging       Date:  2020-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.